Anaesthesia for cardioversion
dc.contributor.author | Stoneham, M. D. | en_US |
dc.date.accessioned | 2010-06-01T20:30:40Z | |
dc.date.available | 2010-06-01T20:30:40Z | |
dc.date.issued | 1996-06 | en_US |
dc.identifier.citation | STONEHAM, M. D. (1996). "Anaesthesia for cardioversion." Anaesthesia 51(6): 565-570. <http://hdl.handle.net/2027.42/73622> | en_US |
dc.identifier.issn | 0003-2409 | en_US |
dc.identifier.issn | 1365-2044 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/73622 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=8694211&dopt=citation | en_US |
dc.description.abstract | Cardioversion is a minor procedure requiring sedation and analgesia. However, it is often performed out-of-hours in remote sites by inexperienced anaesthetists. An understanding is required both of the pathophysiology underlying cardiac arrhythmias and of the technical side of defibrillation equipment, including electrical safety. Patients should have their coagulation status and electrolyte balance checked prior to the procedure to reduce the likelihood of complications. Almost all the available anaesthetic agents have been used for cardioversion in the past, with varying degrees of success. The anaesthetic agent chosen for patients undergoing cardioversion must provide analgesia and sedation, cause the least cardiovascular compromise possible and still enable rapid recovery. Propofol may be the closest anaesthetic agent to this ideal currently available, although careful titration of any agent chosen is also important. Cardioversion may be performed as an emergency, including in the pregnant patient, providing safe anaesthetic practice is followed. | en_US |
dc.format.extent | 655455 bytes | |
dc.format.extent | 3109 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Blackwell Publishing Ltd | en_US |
dc.rights | 1996 The Association of Anaesthetists of Great Britain and Ireland | en_US |
dc.subject.other | Cardioversion; Defibrillation; Equipment; Defibrillator | en_US |
dc.title | Anaesthesia for cardioversion | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Surgery and Anesthesiology | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | M.D. Stoneham, MA, FRCA, Visiting Instructor, Department of Anesthesia, University of Michigan Medical Center, Ann Arbor, Michigan MI 48109–0048. USA. | en_US |
dc.identifier.pmid | 8694211 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/73622/1/j.1365-2044.1996.tb12566.x.pdf | |
dc.identifier.doi | 10.1111/j.1365-2044.1996.tb12566.x | en_US |
dc.identifier.source | Anaesthesia | en_US |
dc.identifier.citedreference | [1] Annual Reports of the Royal Humane Society, for the Recovery of the Apparently Drowned. London 1774; 1: 31. | en_US |
dc.identifier.citedreference | Prevost JL, Batelli F. Sur quelques effets des descharges electriques sur le coeur des manimiferes. Comptes Rendus de l'Academic des Sciences 1899; 129: 1267. | en_US |
dc.identifier.citedreference | Beck CS Pritchard WH, Feil HS. Ventricular fibrillation of long duration abolished by electrical shock. Journal of the American Medical Association 1947; 135: 985 – 6. | en_US |
dc.identifier.citedreference | Lown B, Amarsingham R, Neuman J. New method for terminating cardiac arrhythmias. Journal of the American Medical Association 1962; 182: 548 – 55. | en_US |
dc.identifier.citedreference | Hill. DW. Electronic techniques in anaesthesia and surgery, 2nd edn. London: Butterworths; 1973. | en_US |
dc.identifier.citedreference | Kouwenhoven WB. The development of the defibrillator. Annals of Internal Medicine. 1969; 71: 449 – 58. | en_US |
dc.identifier.citedreference | Pantridge JF Geddes JS. A mobile intensive care unit in the management of myocardial dysfunction. Lancet 1967; 5: 271 – 3. | en_US |
dc.identifier.citedreference | Cummins RO, Eisenburg MS, Litwin PE. Automatic external defibrillators used by emergency medical technicians: A controlled clinical trial. Journal of the American Medical Association 1987; 257: 1605 – 10. | en_US |
dc.identifier.citedreference | Mirowski M. Reid PR, Mower MM. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. New England Journal of Medicine 1980; 303: 322 – 4. | en_US |
dc.identifier.citedreference | Kowey PR. The calamity of cardioversion of conscious patients. American Journal of Cardiology 1988; 61: 1106 – 7. | en_US |
dc.identifier.citedreference | Zipes DP, Fischer J. King RM. Termination of ventricular fibrillation in dogs by depolarizing a critical amount of myocardium. American Journal of Cardiology 1975; 36: 37 – 44. | en_US |
dc.identifier.citedreference | Parbrook GD, Davis PD, Parbrook EO. Basic Physics and Measurement in Anaesthesia. 4th edn. Oxford: Butterworth-Heinemann. 1990. | en_US |
dc.identifier.citedreference | Sirna SJ, Ferguson DW, Charbonnier F, Kerber RE. Factors affecting transthoracic impedance during electrical cardioversion. American Journal of Cardiology 1988; 62: 1048 – 52. | en_US |
dc.identifier.citedreference | Dalzell GW, Anderson J. Adgey AA. Factors determining success and energy requirements for cardioversion of atrial fibrillation: revised version. Quarterly, Journal of Medicine. 1991; 78: 85 – 95. | en_US |
dc.identifier.citedreference | DeSilva RA, Graboys TB, Podrid PJ, Lown B. Cardioversion and defibrillation. American Heart Journal 1980; 100: 881 – 95. | en_US |
dc.identifier.citedreference | Kerber RE, Jensen SR, Grayzel J, Kennedy J, Hoyt R. Elective cardioversion: influence of paddle-electrode location and size on success rates and energy requirements. New England Journal of Medicine 1981; 305: 658 – 62. | en_US |
dc.identifier.citedreference | Rogove HJ, Hughes CM. Defibrillation and cardioversion. Critical Care Clinics 1992; 8: 839 – 63. | en_US |
dc.identifier.citedreference | Yurchak PM, Williams SV, Achord JL, Reynolds WA, Fisch C, Friesinger GC, Klocke FJ, Akhtar M, Ryan TJ, Schlant RC. Clinical competence in elective direct current (DC) cardioversion. A statement for physicians from the AHA/ACC/ACP Task Force on Clinical Privileges in Cardiology. Circulation 1993; 88: 342 – 5. | en_US |
dc.identifier.citedreference | Kerber RE, Carter J, Klein S. Open chest defibrillation during cardiac surgery: energy and current requirements. American Journal of Cardiology 1980; 46: 393 – 6. | en_US |
dc.identifier.citedreference | Mushin WW, Jones PL. Physics for the Anaesthetist, 2nd edn. Oxford: Blackwell Scientific Publications, 1987. | en_US |
dc.identifier.citedreference | Kerber RE. Electrical treatment of cardiac arrhythmias: defibrillation and cardioversion. Annals of Emergency Medicine 1993; 22: 296 – 301. | en_US |
dc.identifier.citedreference | Clark A, Cotter L. Cardioversion in atrial fibrillation. British Journal of Hospital Medicine 1993; 49: 256 – 61. | en_US |
dc.identifier.citedreference | Manninen PH. Anaesthesia outside the operating room. Canadian Journal of Anaesthesia 1991; 38: R126 – 9. | en_US |
dc.identifier.citedreference | [24] Association of Anaesthetists of Great Britain and Ireland. Recommendations for Standards of Monitoring during Anaesthesia nnd Recovery. London: AAGBI, 1994. | en_US |
dc.identifier.citedreference | Arnold AZ, Mick MJ, Mazurek RP, Loop FD, Trohman RG. Role of prophylactic anticoagulation for direct current cardioversion in patients with atrial fibrillation or atrial flutter. Journal of the American College of Cardiology, 1992; 19: 851 – 5. | en_US |
dc.identifier.citedreference | Orko R. Anaesthesia for cardioversion: thiopentone with and without atropine premedication. British Journal of Anaesthesia 1974; 46: 947 – 52. | en_US |
dc.identifier.citedreference | Kernohan RJ. Diazepam in cardioversion. Lancet 1966; i: 718 – 19. | en_US |
dc.identifier.citedreference | Winters WL, McDonough MT, Hafer J, Dietz R. Diazepam: a useful hypnotic drug for direct current cardioversion. Journal of the American Medical Association 1968; 204: 926 – 8. | en_US |
dc.identifier.citedreference | Tiongson JG, Jr. Helmuth J. Austin M. Linde C. Comparison of diazepam and sodium methohexital in elective DC cardioversion. Delaware Medical Journal 1978; 50: 601 – 3. | en_US |
dc.identifier.citedreference | Knapp RB, Dubow H. Diazepam and cardiopulmonary disease. Anesthesia and Analgrsia: Current Research 1970; 49: 722 – 6. | en_US |
dc.identifier.citedreference | Muenster JJ, Rosenburg MS, Carleton RA, Graettinger JS. Comparison between diazepam and sodium thiopental during DC countershock. Journal of the American Medical Association 1967; 199: 758 – 60. | en_US |
dc.identifier.citedreference | Orko R. Anaesthesia for cardioversion: a comparison of diazepam, thiopentone and propanidid. British Journal of Anaesthesia 1976; 48: 257 – 62. | en_US |
dc.identifier.citedreference | Krichbaum DW, Hamid I. Midazolam sedation and amnesia in elective cardioversion. Clinical Pharmacy. 1988; 7: 423. | en_US |
dc.identifier.citedreference | Gupta A. Vegfors M, Lennmarken C. Midazolam and cardioversion. British Journal of Anaesthesia 1992; 69: 422. | en_US |
dc.identifier.citedreference | Fennelly ME, Powell H, Galletly DC, Whitwam JG. Midazolam sedation reversed by flumazenil for cardioversion. British Journal of Anaesthesia 1992; 68: 303 – 5. | en_US |
dc.identifier.citedreference | Gupta A, Lennmarken C. Vegfors M, Tyden H. Anaesthesia for cardioversion. A comparison between propofol, thiopentone and midazolain. Anaesthesia 1990; 45: 872 – 5. | en_US |
dc.identifier.citedreference | Vatashky E. Flunitrazepam for cardioversion. Anaesthesia 1981; 36: 536. | en_US |
dc.identifier.citedreference | Hooker DR, Kouwenhoven WB, Langworthy OR. The effect of alternating electrical currents on the heart. American Journal of Physiology 1933; 103: 444. | en_US |
dc.identifier.citedreference | Canessa R. Lema G, Urzua J, Dagnino J, Concha M. Anesthesia for elective cardioversion: a comparison of four anesthetic agents. Journal of Cardiothoracic and Vascular Anesthesia 1991; 5: 566 – 8. | en_US |
dc.identifier.citedreference | Ford SR, Maze M. Gaba DM. A comparison of etomidate and thiopental anesthesia for cardioversion. Journal of Cardiothoracic and Vascular Anesthesica 1991; 5: 563 – 5. | en_US |
dc.identifier.citedreference | Valtonen M, Kanto J, Klossnfr J. Anaesthesia for cardioversion: a comparison of propofol and thiopentone. Canadian Journal of Anaesthesia 1988; 35: 479 – 83. | en_US |
dc.identifier.citedreference | Orko R, Malmivuo J. Anaesthesia for cardioversion: immediate haemodynainics in patients anaesthetized with thiopental or althesin. Annals of Clinical Research 1976; 8: 248 – 53. | en_US |
dc.identifier.citedreference | Gale DW, Grissom TE, Mirenda JV. Titration of intravenous anesthetics for cardioversion: a comparison of propofol, methohexital, and midazolam. Critical Care Medicine 1993; 21: 1509 – 13. | en_US |
dc.identifier.citedreference | White PF. Use of thiopental-lidocaine combination for elective cardioversion. Anesthesiology 1984; 60: 511 – 12. | en_US |
dc.identifier.citedreference | Watt I, Ledingham IM. Mortality amongst multiple trauma patients admitted to an intensive therapy unit. Anaesthesia 1984; 39: 973 – 81. | en_US |
dc.identifier.citedreference | Shulman MS, Edelmann R. Use of etomidate for elective cardioversion. Anesthsiology 1988; 68: 656. | en_US |
dc.identifier.citedreference | Hullander RM, Leivers D, Wingler K. A comparison of propofol and etomidate for cardioversion. Anesthesia and Analgesia 1993; 77: 690 – 4. | en_US |
dc.identifier.citedreference | Hagemeijer F, Van Mechelen R, Smalbraak DW. Fentanyl-etomidate anesthesia for cardioversion. European Heart Journal 1982; 3: 155 – 8. | en_US |
dc.identifier.citedreference | Mitterschiffthaler G. Lechleitner P, Hauptlorenz S, Wencker M, Dienstl F. [Anesthesia for cardioversion. A comparison of propofol and etomidate]. [French]. Cahiers d'Anesthesiologie 1990; 38: 159 – 63. | en_US |
dc.identifier.citedreference | Fry DE, Griffiths H. The inhibition by etomidate of 11b hydroxylation of cortisol. Clinical Endocrinology 1984; 20: 625 – 9. | en_US |
dc.identifier.citedreference | Sternlo JE, Hagerdal M. Anaesthesia for cardioversion—clinical experiences with propofol and thiopentone. Acta Anaesthesiologica Scandinavica 1991; 35: 606 – 8. | en_US |
dc.identifier.citedreference | Lechleitner P, Genser N. Mitterschiffthaler G. Dienstl F. Propofol for direct current cardioversion in cardiac risk patients. European heart Journal 1991; 12: 813 – 17. | en_US |
dc.identifier.citedreference | Heinonen J. Orko R, Louhija A. Anaesthesia for cardioversion: a comparison of althesin and thiopentone. British Journal of Anaesthesia 1973; 45: 49 – 54. | en_US |
dc.identifier.citedreference | Myint Y, Peacock JE, Reilly CS. Induction of anaesthesia with eltanolone at different rates of induction in elderly patients. British Journal of Anaesthesia 1994; 73: 771 – 4. | en_US |
dc.identifier.citedreference | [55] Anonymous. Preoxygenation: physiology and practice. Lancet 1992; 339: 31 – 2. | en_US |
dc.identifier.citedreference | Kashyap L. Yaddanapudi LN. Sandhya. Arterial desaturation during induction with and without preoxygenation: evaluation of four techniques. Anaesthesia and Intensive Care 1993; 21: 811 – 13. | en_US |
dc.identifier.citedreference | Klepper I. Cardioversion in late pregnancy. The anaesthetic management of a case of Wolff-Parkinson-White syndrome. Anaesthesia 1981; 36: 611 – 16. | en_US |
dc.identifier.citedreference | Finlay AY, Edmunds V. DC cardioversion in pregnancy. British Journal of Clinical Practice 1979; 33: 88. | en_US |
dc.identifier.citedreference | Field LM, Barton FL. The management of anaesthesia for caesarean section in a patient with paroxysmal ventricular tachycardia. Anaesthesia 1993; 48: 593 – 5. | en_US |
dc.identifier.citedreference | Schroeder JS, Harrison DC. Repeated cardioversion during pregnancy. American Journal of Cardiology 1971; 27: 445 – 6. | en_US |
dc.identifier.citedreference | Vera Z, Bommer WJ, Desai JM. Ventricular fibrillation following elective cardioversion in a patient with perinanent pacemaker. Pacing and Clinical Electrophysiology 1990; 13: 568 – 70. | en_US |
dc.identifier.citedreference | Ebrahimi R. Rubin SA. Electrical cardioversion resulting in death from synchronization failure. American Journal of Cardiology 1994; 74: 100 – 2. | en_US |
dc.identifier.citedreference | Jakobsson J, Odmansson I, Nordlander R. Enzyme release after elective cardioversion. European Heart Journal 1990; II: 749 – 52. | en_US |
dc.identifier.citedreference | Garcia-Rubira JC, Romero D. Garcia JT, Lopez V, Cruz JM. Transient myocardial injury after elective electrical cardioversion. International Journal of Cardiology 1994; 46: 283 – 5. | en_US |
dc.identifier.citedreference | Minor RL Jr, Chandram PK, Williams CL. Rhabdoniyolysis and myoglobinuric renal failure following cardioversion and CPR for acute MI. Chest 1990; 97: 485 – 6. | en_US |
dc.identifier.citedreference | DiMarco JP. Further evidence in support of anticoagulant therapy before elective cardioversion of atrial fibrillation. Journal of the American College of Cardiology. 1992; 19: 856 – 7. | en_US |
dc.identifier.citedreference | Conti CR. Atrial fibrillation, transesophageal echo, electrical cardioversion, and anticoagulation. Clinical Cardiology, 1994; 17: 639 – 40. | en_US |
dc.identifier.citedreference | Mehta PM, Reddy BR, Lesser J. Carson PE. Severe bradycardia following electrical cardioversion for atrial tachyarrhythmias in patients with acute myocardial infarction. Chest 1990; 97: 241 – 2. | en_US |
dc.identifier.citedreference | [69] Emergency Care Research Institute. Hazard: defibrillation in oxygen-enriched environments. Health Devices 1987; 16: 113 – 16. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe its collections in a way that respects the people and communities who create, use, and are represented in them. We encourage you to Contact Us anonymously if you encounter harmful or problematic language in catalog records or finding aids. More information about our policies and practices is available at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.